Healthcare provider profile · identity verified

Kenneth G. Cook, MD

Family Practice · PADUCAH, KY · NPI 1720169501

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	328	115
Simvastatin	Simvastatin	300	103
Amlodipine Besylate	Amlodipine Besylate	267	98
Alprazolam	Alprazolam	252	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	221	79
Metoprolol Succinate	Metoprolol Succinate	219	83
Omeprazole	Omeprazole	195	70
Gabapentin	Gabapentin	186	65
Zolpidem Tartrate	Zolpidem Tartrate	184	39
Metformin Hcl	Metformin Hcl	182	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	180	53
Lisinopril	Lisinopril	180	66
Pantoprazole Sodium	Pantoprazole Sodium	178	62
Losartan Potassium	Losartan Potassium	159	55
Rosuvastatin Calcium	Rosuvastatin Calcium	155	58
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	154	56
Metoprolol Tartrate	Metoprolol Tartrate	152	55
Pravastatin Sodium	Pravastatin Sodium	127	45
Tamsulosin Hcl	Tamsulosin Hcl	124	41
Levothyroxine Sodium	Levothyroxine Sodium	122	48
Hydrochlorothiazide	Hydrochlorothiazide	110	37
Allopurinol	Allopurinol	105	33
Meloxicam	Meloxicam	104	36
Escitalopram Oxalate	Escitalopram Oxalate	98	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	33
Citalopram Hbr	Citalopram Hydrobromide	83	23
Eliquis	Apixaban	81	22
Furosemide	Furosemide	81	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	25
Synthroid	Levothyroxine Sodium	80	23
Tramadol Hcl	Tramadol Hcl	80	16
Clopidogrel	Clopidogrel Bisulfate	75	29
Glipizide Er	Glipizide	73	25
Atenolol	Atenolol	70	24
Glimepiride	Glimepiride	61	24
Jardiance	Empagliflozin	61	16
Glipizide	Glipizide	59	18
Tizanidine Hcl	Tizanidine Hcl	59	22
Celecoxib	Celecoxib	55	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	19
Ozempic	Semaglutide	50	11
Amoxicillin	Amoxicillin	49	39
Diclofenac Sodium	Diclofenac Sodium	49	18
Duloxetine Hcl	Duloxetine Hcl	49	13
Diazepam	Diazepam	47	15
Nifedipine Er	Nifedipine	46	20
Esomeprazole Magnesium	Esomeprazole Magnesium	45	14
Metformin Hcl Er	Metformin Hcl	41	14
Potassium Chloride	Potassium Chloride	41	15
Clonidine Hcl	Clonidine Hcl	38	14
Finasteride	Finasteride	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	11
Fluconazole	Fluconazole	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	22
Trazodone Hcl	Trazodone Hcl	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	11
Verapamil Er	Verapamil Hcl	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	16
Bupropion Xl	Bupropion Hcl	30	suppressed
Cephalexin	Cephalexin	30	23
Ezetimibe	Ezetimibe	30	12
Memantine Hcl	Memantine Hcl	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	11
Estradiol	Estradiol	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	22
Clonazepam	Clonazepam	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Azithromycin	Azithromycin	25	22
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Rizatriptan	Rizatriptan Benzoate	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Topiramate	Topiramate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Ramipril	Ramipril	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Naproxen	Naproxen	15	suppressed
Indomethacin	Indomethacin	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Sertraline Hcl	Sertraline Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error